Projects

International

• Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
  Program: ERANET
  Duration: 1. 9. 2024 – 31. 8. 2027

National

• Targeting high-order chromatin regulation for the treatment of poor prognosis uveal melanoma
  Program: SRDA
  Duration: 1. 7. 2024 – 30. 6. 2028

• DNA methylation biomarkers as a tool for the implementation of liquid biopsy in uveal melanoma
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Innovative approaches to the diagnosis and treatment of pancreatic ductal adenocarcinoma
  Program:
  Duration: 1. 9. 2024 – 30. 6. 2026

• Reprogramming pancreatic ductal adenocarcinoma microenvironment towards immunotherapy
  Program: SRDA
  Duration: 1. 7. 2022 – 30. 6. 2026

• Verification of clinically relevant biomarkers for the stratification of CRC patients by molecular and bioinformatic methods.
  Program: VEGA
  Duration: 1. 1. 2022 – 31. 12. 2025

• Suicide gene therapy mediated by mesenchymal stromal and pancreatic tumor cell-excreted extracellular vesicles in the treatment of pancreatic ductal adenocarcinoma
  Program: SRDA
  Duration: 1. 7. 2021 – 30. 6. 2025

• Identification of potential therapeutic targets associated with cisplatin resistance in yolk sac tumors
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Development of patients derived xenografts models and their utilization for personalized treatment of uveal melanoma
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Regulation of epithelial-mesenchymal transition by microRNA and promoter methylation in invasive breast cancer
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2022

• Expression analysis of miRNA genes regulating the biology of cancer stem cells in breast cancer patients
  Program: VEGA
  Duration: 1. 1. 2017 – 31. 12. 2020

• DNA methylation profiles in genes associated with breast cancer metasasising
  Program: VEGA
  Duration: 1. 1. 2015 – 31. 12. 2018

• Histone modification and DNA methylation relationship in transcription silencing of cancer associated genes
  Program: VEGA
  Duration: 1. 1. 2013 – 31. 12. 2016

• Implementation of methods for analysis of epigenetic changes in genes involved in epithelial-mesenchymal transition in breast cancer
  Program: VEGA
  Duration: 1. 1. 2014 – 31. 12. 2016

• Identification of predictive epigenetic biomarkers in breast cancers
  Program: SRDA
  Duration: 1. 5. 2011 – 31. 8. 2014

• Epigenetic inactivation of selected genes for growth, invazivity and metastasis regulation in breast cancers
  Program: VEGA
  Duration: 1. 1. 2010 – 31. 12. 2012

• Implementation of histology and molecular-biology methods in the tumor heterogenity analysis
  Program: Intra-constitutional
  Duration: 1. 1. 2010 – 31. 12. 2010